This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Tao Pei, PhD
Senior Vice President, Chemistry at Arrowhead Pharmaceuticals
Speaker

Profile

Dr. Tao Pei is the Senior VP of Discovery Chemistry at Arrowhead Pharmaceuticals. In this role, he leads multiple functional groups in the exploration and development of TRiM™ platforms for targeted siRNA delivery to several extrahepatic tissues including lung, skeletal muscle, adipose, eye, and CNS. Tao is a key architect of Arrowhead’s TRiM™ technology and contributor to the final design of Arrowhead’s first TRiM™ candidate, Olpasiran—now in Phase III clinical trials. Tao earned his PhD in chemistry from Duke University where he performed research in Dr. Ross Widenhoefer’s lab.